Quantum-Si Signs Lease for New Headquarters in New Haven
January 04 2022 - 8:00AM
Business Wire
Quantum-Si will begin relocating to the
landmark Winchester Works site in the first half of 2022
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or
the “Company”), a life sciences tools company commercializing a
unique protein sequencing platform, today announced that it has
entered into a lease agreement with Winchester Office LLC to
develop a new headquarters at Winchester Works, a technology and
life sciences building across the street from Yale’s Science
Hill.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220104005338/en/
Winchester Works (source:
JLL/Quantum-Si)
The new headquarters will consist of a state-of-the-art,
mixed-use space that is approximately 65,000 square-feet and will
house office and core research and development space. Winchester
Office LLC comprises LMXD – an affiliated company of L+M
Development Partners – Twining Properties and the Goldman Sachs
Urban Investment Group.
Quantum-Si will begin relocating to the new headquarters in the
first half of 2022. In June 2021, Quantum-Si also had announced the
lease of a new product development and operations facility in San
Diego which opened in the third quarter of 2021.
“Our combined campuses in Connecticut and California will be the
cornerstone of growth for both research and development and
commercial operations,” said John Stark, Chief Executive Officer of
Quantum-Si. “Having a presence in these vibrant life sciences hubs
will enable Quantum-Si to recruit high-caliber talent as we
continue to scale up operations ahead of our planned platform
commercial launch in 2022.”
“The life sciences sector is going to play a critical role in
our nation’s post-pandemic recovery, and we believe that New Haven
– particularly the Winchester Works campus – will help with that
resurgence,” said Jake Pine, Senior Director at LMXD. “Quantum-Si
will make a significant impact to an already bustling life science
campus bringing cutting-edge technology and critical jobs to
Winchester Works.”
About Quantum-Si
Founded by Dr. Jonathan Rothberg in 2013, Quantum-Si is focused
on revolutionizing the growing field of proteomics. The Company's
suite of technologies is powered by a first-of-its-kind
semiconductor chip designed to enable single molecule
next-generation protein sequencing and digitize proteomic research
in order to advance drug discovery and diagnostics beyond what has
been possible with DNA sequencing.
About Winchester Works
Built in 2012, the approximately 130,000-square-foot Class A
office building at 115 Munson Street was the first new office
building constructed in New Haven in more than 20 years. Winchester
Office LLC purchased the property in late 2019 and has reimagined
the building with life sciences tenants in mind, overhauling the
entrance and lobby and revamping the rooftop amenity space.
Winchester Works is the first stage in the Winchester Center
master plan, which could eventually include the four development
sites in Science Park at Yale, all part of New Haven CT’s former
Winchester Factory that once employed 25,000 people. Winchester
Center could eventually include over 1,000 apartments, retail space
and 500,000 square feet of office and lab space.
Forward Looking Statements
This press release includes "forward-looking statements" within
the meaning of the "safe harbor" provisions of the United States
Private Securities Litigation Reform Act of 1995. The actual
results of the Company may differ from its expectations, estimates,
and projections and, consequently, you should not rely on these
forward-looking statements as predictions of future events. Words
such as "expect," "estimate," "project," "budget," "forecast,"
"anticipate," "intend," "plan," "may," "will," "could," "should,"
"believes," "predicts," "potential," "continue," and similar
expressions (or the negative versions of such words or expressions)
are intended to identify such forward-looking statements. These
forward-looking statements include, without limitation, the
Company's expectations with respect to future performance and
development and commercialization of products and services, and the
timing for commencing operations at the new facility and the
potential impact of the new facility on our business. These
forward-looking statements involve significant risks and
uncertainties that could cause actual results to differ materially
from those discussed in the forward-looking statements. Most of
these factors are outside the Company's control and are difficult
to predict. Factors that may cause such differences include, but
are not limited to: the impact of COVID-19 on the Company's
business; the inability to maintain the listing of the Company's
shares of Class A common stock on The Nasdaq Stock Market LLC; the
ability to recognize the anticipated benefits of the recently
completed business combination, which may be affected by, among
other things, competition and the ability of the Company to grow
and manage growth profitably and retain its key employees; changes
in applicable laws or regulations; the ability of the Company to
raise financing in the future; the success, cost and timing of the
Company's product development and commercialization activities; the
potential attributes and benefits of the Company's products and
services; the Company's ability to obtain and maintain regulatory
approval for its products, and any related restrictions and
limitations of any approved product; the Company's ability to
identify, in-license or acquire additional technology; the
Company's ability to maintain its existing lease, license,
manufacture and supply agreements; the Company's ability to compete
with other companies currently marketing or engaged in the
development and commercialization of products and services that the
Company is developing; the size and growth potential of the markets
for the Company's future products and services, and its ability to
serve those markets, either alone or in partnership with others;
the pricing of the Company's products and services following
anticipated commercial launch; the Company's estimates regarding
future expenses, future revenue, capital requirements and needs for
additional financing; the Company's financial performance; and
other risks and uncertainties indicated from time to time in the
Company's filings with the U.S. Securities and Exchange Commission.
The Company cautions that the foregoing list of factors is not
exclusive. The Company cautions readers not to place undue reliance
upon any forward-looking statements, which speak only as of the
date made. The Company does not undertake or accept any obligation
or undertaking to release publicly any updates or revisions to any
forward-looking statements to reflect any change in its
expectations or any change in events, conditions, or circumstances
on which any such statement is based.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220104005338/en/
Investor Contacts Juan Avendano Mike Cavanaugh (617)
877-9641 ir@quantum-si.com Media Contact Cammy Duong (203)
682-8380 QSI-PR@westwicke.com
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Jul 2024 to Aug 2024
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Aug 2023 to Aug 2024